Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Discordant immunophenotypic profiles of adhesion molecules and cytokines in acute myeloid leukemia involving bone marrow and skin.

Sachdev R, George TI, Schwartz EJ, Sundram UN.

Am J Clin Pathol. 2012 Aug;138(2):290-9. doi: 10.1309/AJCP34YERPZSCYKQ.

PMID:
22904142
2.

Adhesion molecules on CD34+ hematopoietic cells in normal human bone marrow and leukemia.

Reuss-Borst MA, Bühring HJ, Klein G, Müller CA.

Ann Hematol. 1992 Oct;65(4):169-74.

PMID:
1384721
3.

Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria.

Kaddu S, Zenahlik P, Beham-Schmid C, Kerl H, Cerroni L.

J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):966-78.

PMID:
10365929
4.
5.

Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.

Ghannadan M, Wimazal F, Simonitsch I, Sperr WR, Mayerhofer M, Sillaber C, Hauswirth AW, Gadner H, Chott A, Horny HP, Lechner K, Valent P.

Am J Clin Pathol. 2003 May;119(5):663-71.

PMID:
12760284
6.

An updated approach to the diagnosis of myeloid leukemia cutis.

Cronin DM, George TI, Sundram UN.

Am J Clin Pathol. 2009 Jul;132(1):101-10. doi: 10.1309/AJCP6GR8BDEXPKHR.

PMID:
19864240
8.

Immunophenotyping of acute lymphoblastic leukaemia in routinely processed bone marrow biopsy specimens.

Toth B, Wehrmann M, Kaiserling E, Horny HP.

J Clin Pathol. 1999 Sep;52(9):688-92.

9.

High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).

Graf M, Reif S, Hecht K, Pelka-Fleischer R, Kroell T, Pfister K, Schmetzer H.

Ann Hematol. 2005 May;84(5):287-97. Epub 2004 Dec 7.

PMID:
15592672
10.

Leukemia cutis from CD56 positive, myeloperoxidase negative acute myeloid leukemia.

Abdou AG, Seleit I, Bakry OA, Abdel-Wahed MM.

Acta Dermatovenerol Croat. 2013;21(3):189-92.

PMID:
24183224
11.

Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells.

Liesveld JL, Winslow JM, Frediani KE, Ryan DH, Abboud CN.

Blood. 1993 Jan 1;81(1):112-21.

12.

Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates.

Kaiserling E, Horny HP, Geerts ML, Schmid U.

Mod Pathol. 1994 Sep;7(7):771-9.

PMID:
7824512
13.

Different expression of adhesion molecules on myeloid and B-lymphoid CD34+ progenitors in normal bone marrow.

De Waele M, Renmans W, Damiaens S, Flament J, Schots R, Van Riet I.

Eur J Haematol. 1997 Nov;59(5):277-86.

PMID:
9414638
14.

CD117/CD34 expression in leukemic blasts.

Wells SJ, Bray RA, Stempora LL, Farhi DC.

Am J Clin Pathol. 1996 Aug;106(2):192-5.

PMID:
8712172
15.

The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.

Gallay N, Anani L, Lopez A, Colombat P, Binet C, Domenech J, Weksler BB, Malavasi F, Herault O.

Cancer Res. 2007 Sep 15;67(18):8624-32.

17.

CD56+ blastic transformation of chronic myeloid leukemia involving the skin.

Kaddu S, Beham-Schmid C, Zenahlik P, Kerl H, Cerroni L.

J Cutan Pathol. 1999 Nov;26(10):497-503.

PMID:
10599940
18.

Cutaneous infiltrates of acute myelogenous leukemia simulating inflammatory dermatoses.

Martínez-Escanamé M, Zuriel D, Tee SI, Fried I, Massone C, Cerroni L.

Am J Dermatopathol. 2013 Jun;35(4):419-24. doi: 10.1097/DAD.0b013e31826ffe6f.

PMID:
23221486
19.

Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts.

De Waele M, Renmans W, Jochmans K, Schots R, Lacor P, Trullemans F, Otten J, Balduck N, Vander Gucht K, Van Camp B, Van Riet I.

Eur J Haematol. 1999 Sep;63(3):192-201.

PMID:
10485274
20.

Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.

Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.

Eur J Haematol. 2004 Feb;72(2):89-106.

PMID:
14962246

Supplemental Content

Support Center